Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-26

Clinical Trial Update: Continued Early Intervention for Recent-onset Schizophrenia [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating continued early intervention for recent-onset schizophrenia has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Norwegian University of Science and Technology | Conditions: Schizophrenia | Phase 3 | Status: TERMINATED